Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Lou Gehrig

In baseball, three truly is a magic number

The quizmaster gives you one question per decade, ending in 2013.

Chicago Sun-Times

'Almost a saint': Roberto Clemente is as influential as ever 50 years after his death

When Roberto Clemente Jr. woke on the morning of Dec. 31, 1972, he immediately tiptoed to his parents' bedroom to see whether his father was up.

Los Angeles Times

ALS patients contend with $158K price tag on new drug

For two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug for her Lou Gehrig’s disease

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Aaron Judge Could Join an Exclusive Yankees Club

With his new contract in hand, the slugger could earn the franchise’s most prestigious honor.

Sports Illustrated

Biotech Stocks Embrace The Neuroscience Renaissance With Biogen, Amylyx At The Helm

The neuroscience renaissance is here. Biotech stocks are soaring this year on expectations for new treatments in brain-health disorders.

Investors Business Daily

What is ALS and what are the causes?

Progressive neurodegenerative disease suffered by legendary singer Roberta Flack affects nerve cells in the brain and spinal cord

The Independent UK

Roberta Flack announces she has ALS

The iconic singer of "Killing Me Softly" has the condition also known as Lou Gehrig's disease, a representative has announced. For Roberta Flack, it is now "impossible to sing and not easy to speak."

WEKU

Read news from The Economist, FT, and more,
with one subscription

'It's the right time.' Dodgers legend Jaime Jarrín ready to sign off with gratitude.

LOS ANGELES — Last week, before a game against the Arizona Diamondbacks, the Dodgers honored employees who have worked for the organization for at least 25 years.

Los Angeles Times

ALS drug gets rare second review at high-stakes FDA meeting

The Food and Drug Administration is holding an unusual second meeting to review a closely watched drug for the illness known as Lou Gehrig’s disease

The Independent UK

Bill Madden: Yankees need to right a wrong and honor Graig Nettles with a plaque in Monument Park

NEW YORK — The Yankees’ celebration of Paul O’Neill with the retiring of his No. 21 last week was a response to the overwhelming popularity of one of their most respected players ever and pretty much completed the honored presence of the 1996-2000 Joe Torre dynastic Yankees in Monument Park.

Tribune News Service

Baseball trivia in search of a theme

Before taking this quiz, let’s take a moment to honor Tony Dow, ‘Leave it to Beaver’ and its evocative tune

Chicago Sun-Times

SI:AM | How deGrom Impacts the Second Half

Plus, the “homework clause” in Kyler Murray’s contract is no more

Sports Illustrated

This baseball quiz is finally catching up to June

Much like delayed season, the timing of these questions seems to be a little behind

Chicago Sun-Times

SI:AM | Who, What and How to Watch as the WNBA Season Begins

Is this the year that the Sun finally get over the hump?

Sports Illustrated

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

John Romano: The slightly unhinged case for Wander Franco and 3,000 hits

ST. PETERSBURG, Fla. — So here’s a crazy thought:

The Conversation

ALS is only 50% genetic – identifying DNA regions affected by lifestyle and environmental risk factors could help pinpoint avenues for treatment

Amyotrophic lateral sclerosis is a devastating neurodegenerative disease that affects about 1 in 50,000 people. Well-known people who suffered from ALS include baseball player Lou Gehrig, who lived two years after he was diagnosed, and scientist Stephen Hawking, who lived for an extraordinary 55 years after his diagnosis. While the…

Sports Illustrated

The Yankees Can’t Replace Aaron Judge. That’s Why He’s Going to Free Agency.

He’s a homegrown slugger with a marketable brand all his own. He and New York soon will find out how much that’s worth.

The Conversation

New AI technique identifies dead cells under the microscope 100 times faster than people can – potentially accelerating research on neurodegenerative diseases like Alzheimer's

Understanding when and why a cell dies is fundamental to the study of human development, disease and aging. For neurodegenerative diseases such as Lou Gehrig’s disease, Alzheimer’s and Parkinson’s, identifying dead and dying neurons is critical to developing and testing new treatments. But identifying dead cells can be tricky and…

Get all your
news in one place.

100’s of premium titles.
One news app.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.